BioLife Solutions Inc (BLFS)

Debt-to-assets ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Long-term debt	US$ in thousands	4,997	7,823	10,451	15,681	17,561	20,937	23,572	23,692	23,793	24,207	6,188	6,313	6,353	6,122	5,019	916	655	—	—	—
Total assets	US$ in thousands	399,487	381,652	374,976	401,602	412,714	411,152	433,177	446,470	450,229	488,020	470,681	544,279	554,286	559,391	520,969	240,024	234,829	195,887	113,970	94,987
Debt-to-assets ratio		0.01	0.02	0.03	0.04	0.04	0.05	0.05	0.05	0.05	0.05	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00

December 31, 2024 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $4,997K ÷ $399,487K
= 0.01

The debt-to-assets ratio of BioLife Solutions Inc has been consistently low from March 2020 to June 2022, indicating a conservative approach to financing its operations and investments. However, there has been a gradual increase in the ratio from September 2022 to December 2024, suggesting a slight shift towards using more debt to finance the company's assets. By the end of December 2024, the ratio had decreased slightly from its peak, but it is still higher compared to the earlier years in the period analyzed. This change may indicate a strategic decision to leverage debt for growth opportunities or could be a result of changes in the company's capital structure. Further analysis would be needed to understand the implications of this trend on the company's financial health and risk profile.